🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Doximity stock soars to 52-week high, hits $37.57

Published 12/09/2024, 14:40
DOCS
-

In a remarkable display of resilience, Doximity Inc. (NYSE:DOCS) stock has achieved a new 52-week high, reaching a price level of $37.57. This milestone underscores a significant turnaround for the company, which has seen its stock value surge by an impressive 71.06% over the past year. Investors have shown renewed confidence in Doximity's business model and growth prospects, propelling the stock to this new height. The company's performance is particularly noteworthy in the context of the broader market trends and sets a positive tone for its future trajectory.


In other recent news, Doximity has been in the spotlight following a series of noteworthy developments. The company's recent annual meeting saw the re-election of two Class III directors and the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2025.


Several analyst firms have also revised their outlook on Doximity following the release of its first-quarter results and updated fiscal year 2025 guidance. Jefferies maintained a Buy rating on Doximity and increased the price target to $43.00. Similarly, Canaccord Genuity maintained a Buy rating, expressing confidence in the company's new Portal offering. Truist Securities increased its FY25 revenue estimate for Doximity to $522.8 million.


Meanwhile, Piper Sandler raised its price target for Doximity to $31.00, influenced by the company's strong earnings. Needham upgraded its rating on Doximity to Buy, citing strong momentum with large customers and new product innovations. However, Wells Fargo (NYSE:WFC) downgraded Doximity's shares and reduced the price target to $19.00. These updates reflect the latest developments in Doximity's business operations and financial performance.


InvestingPro Insights


As Doximity Inc. (DOCS) celebrates its new 52-week high, the company's financial health and market performance offer additional insights for investors. An InvestingPro Tip highlights that management's aggressive share buyback strategy may be a vote of confidence in the company's value. Moreover, Doximity holds a stronger cash position than debt on its balance sheet, suggesting a solid financial foundation. For those interested in the fine print of investment analytics, InvestingPro provides further tips, with 15 additional insights available for Doximity at InvestingPro.


InvestingPro Data shows a market capitalization of $6.88 billion, reflecting the company's substantial growth. The price-to-earnings (P/E) ratio stands at 43.08, with an adjusted P/E for the last twelve months as of Q1 2025 at 40.68, indicating a high valuation relative to earnings. However, the PEG ratio, which accounts for earnings growth, is near the benchmark of 1 at 0.99, suggesting that the stock price may be more reasonable when considering future earnings growth. The company's gross profit margin is an impressive 89.65%, demonstrating Doximity's ability to maintain profitability. These metrics, together with a 67.18% one-year price total return, paint a picture of a company that has performed well recently and may continue to attract investor interest.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.